These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12683700)

  • 1. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure.
    Shapiro BP; Chen HH; Burnett JC; Redfield MM
    Mayo Clin Proc; 2003 Apr; 78(4):481-6. PubMed ID: 12683700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?
    Rodeheffer RJ
    J Am Coll Cardiol; 2004 Aug; 44(4):740-9. PubMed ID: 15312852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.
    Vanderheyden M; Vrints C; Verstreken S; Bartunek J; Beunk J; Goethals M
    Biomark Med; 2010 Apr; 4(2):315-20. PubMed ID: 20406072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers in heart failure: BNP and NT-proBNP].
    Ho CC; Liu CC
    Hu Li Za Zhi; 2009 Oct; 56(5):16-22. PubMed ID: 19760573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A basic guide to understanding plasma B-type natriuretic peptide in the diagnosis of congestive heart failure.
    Kreiger G
    Medsurg Nurs; 2007 Apr; 16(2):75-8; quiz 79. PubMed ID: 17547263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNP or NTproBNP? A clinician's perspective.
    Steiner J; Guglin M
    Int J Cardiol; 2008 Sep; 129(1):5-14. PubMed ID: 18378336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does bnp testing aid diagnosis of heart failure?
    Drug Ther Bull; 2009 Oct; 47(10):110-3. PubMed ID: 19809084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natriuretic peptides in cardiovascular medicine.
    Munagala VK; Burnett JC; Redfield MM
    Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring heart failure with brain natriuretic peptide].
    Sela B
    Harefuah; 2003 Jan; 142(1):25-31, 78. PubMed ID: 12647486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
    Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
    J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure.
    Kelder JC; Cramer MJ; Verweij WM; Grobbee DE; Hoes AW
    J Card Fail; 2011 Sep; 17(9):729-34. PubMed ID: 21872142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.
    Knudsen CW; Clopton P; Westheim A; Klemsdal TO; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel AS; Omland T
    Ann Emerg Med; 2005 Jun; 45(6):573-80. PubMed ID: 15940086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.
    Schwam E
    Acad Emerg Med; 2004 Jun; 11(6):686-91. PubMed ID: 15175210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Nishikimi T; Matsuoka H
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232833
    [No Abstract]   [Full Text] [Related]  

  • 19. [The importance of plasma B-type natriuretic peptide levels in cardiovascular diseases].
    Duygu H; Türk U; Zoghi M; Nalbantgil S
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):305-11. PubMed ID: 16330398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices.
    Ro R; Thode HC; Taylor M; Gulla J; Tetrault E; Singer AJ
    J Emerg Med; 2011 Dec; 41(6):661-7. PubMed ID: 21620610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.